This year's conference will feature approximately 400 of the most highly regarded and innovative companies across biotechnology, specialty pharmaceuticals, medical technology, medical diagnostics, life science tools, healthcare services and information technology.
The conference attracts an audience of over 2,000 attendees including institutional, private equity and venture investors from the U.S., Asia, Europe and Canada. Additionally, CEOs, industry experts and leading physicians have also been invited to host panels and address the most relevant issues affecting healthcare.
